Oncolytic adenovirus coding for granulocyte macrophage colony-stimulating factor induces antitumoral immunity in cancer patients.

Abstract:

:Granulocyte macrophage colony-stimulating factor (GMCSF) can mediate antitumor effects by recruiting natural killer cells and by induction of tumor-specific cytotoxic T-cells through antigen-presenting cells. Oncolytic tumor cell-killing can produce a potent costimulatory danger signal and release of tumor epitopes for antigen-presenting cell sampling. Therefore, an oncolytic adenovirus coding for GMCSF was engineered and shown to induce tumor-specific immunity in an immunocompetent syngeneic hamster model. Subsequently, 20 patients with advanced solid tumors refractory to standard therapies were treated with Ad5-D24-GMCSF. Of the 16 radiologically evaluable patients, 2 had complete responses, 1 had a minor response, and 5 had disease stabilization. Responses were frequently seen in injected and noninjected tumors. Treatment was well tolerated and resulted in the induction of both tumor-specific and virus-specific immunity as measured by ELISPOT and pentamer analysis. This is the first time that oncolytic virus-mediated antitumor immunity has been shown in humans. Ad5-D24-GMCSF is promising for further clinical testing.

journal_name

Cancer Res

journal_title

Cancer research

authors

Cerullo V,Pesonen S,Diaconu I,Escutenaire S,Arstila PT,Ugolini M,Nokisalmi P,Raki M,Laasonen L,Särkioja M,Rajecki M,Kangasniemi L,Guse K,Helminen A,Ahtiainen L,Ristimäki A,Räisänen-Sokolowski A,Haavisto E,Oksanen M,

doi

10.1158/0008-5472.CAN-09-3567

subject

Has Abstract

pub_date

2010-06-01 00:00:00

pages

4297-309

issue

11

eissn

0008-5472

issn

1538-7445

pii

0008-5472.CAN-09-3567

journal_volume

70

pub_type

杂志文章
  • O6-benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair.

    abstract::Early phase evaluation of anticancer drugs has traditionally used toxicity (usually hematological) rather than efficacy end points to establish appropriate dosing schedules. To establish a biochemical efficacy end point for overcoming alkylguanine DNA alkyltransferase (AGT)-mediated tumor cell resistance to 1,3-bis(2-...

    journal_title:Cancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Spiro TP,Gerson SL,Liu L,Majka S,Haaga J,Hoppel CL,Ingalls ST,Pluda JM,Willson JK

    更新日期:1999-05-15 00:00:00

  • Targeted cancer therapeutics.

    abstract::Targeted therapies can be defined as drugs developed against a specific target based on its important biological function in cancer. In contrast, nontargeted therapies are drugs identified by phenotypic screening of natural products or chemical libraries against established cancer cell lines or preclinical animal mode...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-08-3836

    authors: Hait WN,Hambley TW

    更新日期:2009-02-15 00:00:00

  • The multifaceted retrovirus.

    abstract::I have attempted to illustrate the many different properties of retroviruses and their presence in a wide variety of animal species including humans. Since the turn of this century, progress in the field of retrovirology has been noteworthy and many new and important scientific observations have been made (Table 7). A...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Levy JA

    更新日期:1986-11-01 00:00:00

  • Prooncogenic factors miR-23b and miR-27b are regulated by Her2/Neu, EGF, and TNF-α in breast cancer.

    abstract::miRNAs (miR) are a critical class of small (21-25 nucleotides) noncoding endogenous RNAs implicated in gene expression regulation. We identified miR-23b and miR-27b as miRNAs that are highly upregulated in human breast cancer. We found that engineered knockdown of miR-23b and miR-27b substantially repressed breast can...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-12-2162

    authors: Jin L,Wessely O,Marcusson EG,Ivan C,Calin GA,Alahari SK

    更新日期:2013-05-01 00:00:00

  • Progesterone receptor expression in meningiomas.

    abstract::The possibility that the female sex steroid progesterone plays a role in meningioma proliferation has been suggested by a number of investigators; and it had been shown that many meningiomas have high affinity progesterone binding sites. The aim of this study was to examine the expression of progesterone receptor mRNA...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Carroll RS,Glowacka D,Dashner K,Black PM

    更新日期:1993-03-15 00:00:00

  • Isolation of prostatic acid phosphatase-binding immunoglobulin G from human sera and its potential for use as a tumor-localizing reagent.

    abstract::A human immunoglobulin that binds prostatic acid phosphatases (PAP) was isolated from the serum of normal individuals by affinity chromatography using a PAP-Sepharose solid adsorbent. The yield of isolated protein, termed PAP-binding globulin (PAPBG), ranged from 4.7 to 16.3 microgram/ml serum. As shown by immunoelect...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Papsidero LD,Wojcieszyn JW,Horoszewicz JS,Leong SS,Murphy GP,Chu TM

    更新日期:1980-08-01 00:00:00

  • Prolactin binding to 7,12-dimethylbenz(a)anthracene-induced mammary tumors and liver in diabetic rats.

    abstract::Growth rates of 7,12-dimethylbenz(a)anthracene-induced mammary tumors and the specific 125I-labeled prolactin binding to membrane fractions prepared from livers and tumors were studied in rats made diabetic by streptozotocin injection. Growth was inhibited in a majority of tumors and prolactin binding was reduced in b...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Smith RD,Hilf R,Senior AE

    更新日期:1977-11-01 00:00:00

  • Important role of serotonin in the antitumor effects of recombinant human tumor necrosis factor-alpha in mice.

    abstract::The possible involvement of chemical mediator(s) in the induction of the antitumor effects of recombinant human tumor necrosis factor-alpha (rTNF-alpha) on Meth A fibrosarcoma (Meth A) in mice was studied. On day 7 after intradermal implantation of Meth A in mice, rTNF-alpha caused tumor necrosis and inhibited the tum...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Manda T,Nishigaki F,Mori J,Shimomura K

    更新日期:1988-08-01 00:00:00

  • PDLIM2 Is a Marker of Adhesion and β-Catenin Activity in Triple-Negative Breast Cancer.

    abstract::The PDLIM2 protein regulates stability of transcription factors including NF-κB and STATs in epithelial and hemopoietic cells. PDLIM2 is strongly expressed in certain cancer cell lines that exhibit an epithelial-to-mesenchymal phenotype, and its suppression is sufficient to reverse this phenotype. PDLIM2 supports the ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-18-2787

    authors: Cox OT,Edmunds SJ,Simon-Keller K,Li B,Moran B,Buckley NE,Bustamante-Garrido M,Healy N,O'Flanagan CH,Gallagher WM,Kennedy RD,Bernards R,Caldas C,Chin SF,Marx A,O'Connor R

    更新日期:2019-05-15 00:00:00

  • Resistance to chemotherapy: patient variability and cellular heterogeneity.

    abstract::The issue of resistance to targeted drug therapy is of pressing concern, as it constitutes a major barrier to progress in managing cancer. One important aspect is the role of stochasticity in determining the nature of the patient response. We examine two particular experiments. The first measured the maximal response ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-0118

    authors: Kessler DA,Austin RH,Levine H

    更新日期:2014-09-01 00:00:00

  • Transport and metabolism of 1-beta-D-arabinofuranosylcytosine in human ovarian adenocarcinoma cells.

    abstract::1-beta-D-Arabinofuranosylcytosine (araC) is an effective drug in the i.p. therapy of ovarian carcinoma but little is known of its transport and metabolism in this tumor. Influx of araC at 1 microM into cultured human ovarian carcinoma cells (CI 80-13S) was largely inhibited by nanomolar concentrations of the nucleosid...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Jamieson GP,Snook MB,Bradley TR,Bertoncello I,Wiley JS

    更新日期:1989-01-15 00:00:00

  • Nuclear translocation of the estrogen receptor in autonomous C3H mouse mammary tumors.

    abstract::The reason for estrogen independence of C3H mouse mammary tumors has been sought in the initial steps of estradiol action. The characteristics of the estrogen receptors were similar to those observed in estrogen-responsive tissues: high affinity and binding specificity, DNA binding and 8S sedimentation constant as sho...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Vignon F,Rochefort H

    更新日期:1978-06-01 00:00:00

  • A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library.

    abstract::Libraries of compounds are increasingly becoming commercially available for the use of individual academic laboratories. A high-throughput system based on a stably integrated transcriptional reporter was used to screen a library of random compounds to identify agents that conferred robust augmentation of a signal tran...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Su GH,Sohn TA,Ryu B,Kern SE

    更新日期:2000-06-15 00:00:00

  • Suramin affects DNA synthesis in HeLa cells by inhibition of DNA polymerases.

    abstract::Suramin, a polysulfonated naphthylurea widely used in the treatment of trypanosomiasis and onchocerciasis, is currently being investigated as an antitumor agent for the treatment of advanced cancer. Suramin exerts a wide variety of biological effects. We have shown that suramin inhibits cell proliferation and DNA synt...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Jindal HK,Anderson CW,Davis RG,Vishwanatha JK

    更新日期:1990-12-15 00:00:00

  • Allele separation facilitates interpretation of potential splicing alterations and genomic rearrangements.

    abstract::Mutations that alter normal splice patterns and genomic rearrangements are common causes of hereditary diseases including hereditary nonpolyposis colorectal cancer. However, abnormal transcripts can be difficult to detect and interpret because splicing patterns are often heterogeneous even in normal cells. Standard te...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Nakagawa H,Yan H,Lockman J,Hampel H,Kinzler KW,Vogelstein B,De La Chapelle A

    更新日期:2002-08-15 00:00:00

  • Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin.

    abstract::We evaluated the usefulness of L-dopa decarboxylase (DDC) as a tumor marker of neuroendocrine (NE) cell differentiation by measuring its expression in 432 human tumors of diverse types and origins. A subset of these tumors and cell lines derived from them also were studied for expression of two other general NE cell m...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gazdar AF,Helman LJ,Israel MA,Russell EK,Linnoila RI,Mulshine JL,Schuller HM,Park JG

    更新日期:1988-07-15 00:00:00

  • The role of parental and grandparental epigenetic alterations in familial cancer risk.

    abstract::Epigenetic alterations of the genome such as DNA promoter methylation and chromatin remodeling play an important role in tumorigenesis. These modifications take place throughout development with subsequent events occurring later in adulthood. Recent studies, however, suggest that some epigenetic alterations that influ...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-08-2184

    authors: Fleming JL,Huang TH,Toland AE

    更新日期:2008-11-15 00:00:00

  • Increasing c-FMS (CSF-1 receptor) expression decreases retinoic acid concentration needed to cause cell differentiation and retinoblastoma protein hypophosphorylation.

    abstract::Increasing the expression of c-FMS (colony-stimulating factor 1 receptor) by introduction of a transgene reduced the concentration of retinoic acid or 1,25-dihydroxy vitamin D3 needed to cause myeloid or monocytic cell differentiation and hypophosphorylation of the retinoblastoma tumor suppressor protein (RB) typicall...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Yen A,Sturgill R,Varvayanis S

    更新日期:1997-05-15 00:00:00

  • Connexins act as tumor suppressors in three-dimensional mammary cell organoids by regulating differentiation and angiogenesis.

    abstract::Connexins are tumor suppressors, and human breast connexin 26 (Cx26) and connexin 43 (Cx43) gap junctions are often down-regulated in breast cancer. We previously showed that Cx26 and Cx43 overexpressed in MDA-MB-231 breast cancer cells inhibited tumor growth in vivo but not in two-dimensional cultures. In the current...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-4302

    authors: McLachlan E,Shao Q,Wang HL,Langlois S,Laird DW

    更新日期:2006-10-15 00:00:00

  • Nuclear factor-kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein.

    abstract::Sustained proliferation of cancer cells requires telomerase to maintain telomeres that regulate chromosomal stability and cellular mitosis. Expression of human telomerase reverse transcriptase (hTERT) catalytic subunit, which modulates telomerase activity, is regulated at both the transcriptional level and via phospho...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Akiyama M,Hideshima T,Hayashi T,Tai YT,Mitsiades CS,Mitsiades N,Chauhan D,Richardson P,Munshi NC,Anderson KC

    更新日期:2003-01-01 00:00:00

  • Evolution of Cancer Stem-like Cells in Endocrine-Resistant Metastatic Breast Cancers Is Mediated by Stromal Microvesicles.

    abstract::The hypothesis that microvesicle-mediated miRNA transfer converts noncancer stem cells into cancer stem cells (CSC) leading to therapy resistance remains poorly investigated. Here we provide direct evidence supporting this hypothesis, by demonstrating how microvesicles derived from cancer-associated fibroblasts (CAF) ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-16-2129

    authors: Sansone P,Berishaj M,Rajasekhar VK,Ceccarelli C,Chang Q,Strillacci A,Savini C,Shapiro L,Bowman RL,Mastroleo C,De Carolis S,Daly L,Benito-Martin A,Perna F,Fabbri N,Healey JH,Spisni E,Cricca M,Lyden D,Bonafé M,Bromb

    更新日期:2017-04-15 00:00:00

  • Selective localization of matrix metalloproteinase 9, beta1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells.

    abstract::The shedding of membrane vesicles from the cell surface is a vital process considered to be involved in cell-cell and cell-matrix interactions and in tumor progression. By immunoelectron microscopic analysis of surface replicas of 8701-BC human breast carcinoma cells, we observed that membrane vesicles shed from plasm...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Dolo V,Ginestra A,Cassarà D,Violini S,Lucania G,Torrisi MR,Nagase H,Canevari S,Pavan A,Vittorelli ML

    更新日期:1998-10-01 00:00:00

  • Effects of nonionic detergents on P-glycoprotein drug binding and reversal of multidrug resistance.

    abstract::Multidrug-resistant cells are thought to maintain low intracellular cytotoxic drug concentration though the active efflux of drugs across the cell membrane. It is presently believed that P-glycoprotein mediates this energy-dependent drug efflux by interacting directly with various lipophilic compounds. In this report,...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Zordan-Nudo T,Ling V,Liu Z,Georges E

    更新日期:1993-12-15 00:00:00

  • Influence of bay-region methyl group on formation of 5-methylchrysene dihydrodiol epoxide:DNA adducts in mouse skin.

    abstract::The binding of tritium-labeled 5-methylchrysene to DNA of CD-1 mouse skin 24 hr after treatment has been studied. DNA was isolated from the treated skin areas of mice and hydrolyzed enzymatically to deoxyribonucleosides, and the hydrolysate was chromatographed on a Sephadex LH-20 column using a methanol:water gradient...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Melikian AA,LaVoie EJ,Hecht SS,Hoffmann D

    更新日期:1982-04-01 00:00:00

  • A diphtheria toxin-epidermal growth factor fusion protein is cytotoxic to human glioblastoma multiforme cells.

    abstract::The cytotoxicity of a diphtheria toxin-human epidermal growth factor fusion protein (DAB(389)EGF) was tested against 14 human glioma cell lines. After cells were cultured for 48 h with various concentrations of DAB(389)EGF, the percentage reduction in thymidine incorporation was determined. For 13 of 14 cell lines, po...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Liu TF,Cohen KA,Ramage JG,Willingham MC,Thorburn AM,Frankel AE

    更新日期:2003-04-15 00:00:00

  • Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting of EGF receptor-positive gliomas.

    abstract::Convection enhanced delivery (CED) is potentially a powerful method to improvethe targeting of macromolecules to the central nervous system by applying a pressure gradient to establish bulk flow through the brain interstitium during infusion. The purpose of the present study was to evaluate CED as a means to improve t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Yang W,Barth RF,Adams DM,Ciesielski MJ,Fenstermaker RA,Shukla S,Tjarks W,Caligiuri MA

    更新日期:2002-11-15 00:00:00

  • Tropomodulin 1 expression driven by NF-κB enhances breast cancer growth.

    abstract::Triple-negative breast cancers (TNBC), which include the basal-like and claudin-low disease subtypes, are aggressive malignancies for which effective therapeutic targets are lacking. NF-κB activation has an established role in breast malignancy, and it is higher in TNBC than other breast cancer subtypes. On this basis...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-3455

    authors: Ito-Kureha T,Koshikawa N,Yamamoto M,Semba K,Yamaguchi N,Yamamoto T,Seiki M,Inoue J

    更新日期:2015-01-01 00:00:00

  • Targeting endoplasmic reticulum stress and Akt with OSU-03012 and gefitinib or erlotinib to overcome resistance to epidermal growth factor receptor inhibitors.

    abstract::Preexisting and acquired resistance to epidermal growth factor receptor (EGFR) inhibitors limits their clinical usefulness in patients with advanced non-small cell lung cancer (NSCLC). This study characterizes the efficacy and mechanisms of the combination of gefitinib or erlotinib with OSU-03012, a celecoxib-derived ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-1336

    authors: Wang YC,Kulp SK,Wang D,Yang CC,Sargeant AM,Hung JH,Kashida Y,Yamaguchi M,Chang GD,Chen CS

    更新日期:2008-04-15 00:00:00

  • Generation of antitumor immunity by cytotoxic T lymphocyte epitope peptide vaccination, CpG-oligodeoxynucleotide adjuvant, and CTLA-4 blockade.

    abstract::Although peptide immunization often leads to the induction of strong T-cell responses, it is seldom effective against established tumors. One possibility is that these T-cell responses are not strong enough or do not last sufficiently long to have an effect in tumor eradication. Here, we examined the role of synthetic...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Davila E,Kennedy R,Celis E

    更新日期:2003-06-15 00:00:00

  • PIN1 Maintains Redox Balance via the c-Myc/NRF2 Axis to Counteract Kras-Induced Mitochondrial Respiratory Injury in Pancreatic Cancer Cells.

    abstract::Kras is a decisive oncogene in pancreatic ductal adenocarcinoma (PDAC). PIN1 is a key effector involved in the Kras/ERK axis, synergistically mediating various cellular events. However, the underlying mechanism by which PIN1 promotes the development of PDAC remains unclear. Here we sought to elucidate the effect of PI...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-18-1968

    authors: Liang C,Shi S,Liu M,Qin Y,Meng Q,Hua J,Ji S,Zhang Y,Yang J,Xu J,Ni Q,Li M,Yu X

    更新日期:2019-01-01 00:00:00